Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice.

Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z, Davies E, Hajnóczky G, Saunders TL, Van Keuren ML, Fernandes-Alnemri T, Meisler MH, Alnemri ES.

Nature. 2003 Oct 16;425(6959):721-7. Epub 2003 Oct 8.

2.

The mitochondrial serine protease HtrA2/Omi: an overview.

Vande Walle L, Lamkanfi M, Vandenabeele P.

Cell Death Differ. 2008 Mar;15(3):453-60. doi: 10.1038/sj.cdd.4402291. Epub 2008 Jan 4. Review.

3.

[Mitochondrial serine protease Omi/HtrA2 and apoptosis].

Wang XL, Wang J, Lv XP.

Sheng Li Ke Xue Jin Zhan. 2006 Jul;37(3):285-8. Review. Chinese. No abstract available.

PMID:
17009747
4.

Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target.

Bhuiyan MS, Fukunaga K.

Curr Drug Targets. 2009 Apr;10(4):372-83. Review.

PMID:
19355862
5.

Serine protease mechanism and specificity.

Hedstrom L.

Chem Rev. 2002 Dec;102(12):4501-24. Review. No abstract available.

PMID:
12475199

Supplemental Content

Support Center